Chung, Y. J., Fry, T. J., & Aplan, P. D. (2017). Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome. PLoS One.
Chicago Style CitationChung, Yang Jo, Terry J. Fry, i Peter D. Aplan. "Myeloablative Hematopoietic Stem Cell Transplantation Improves Survival but Is Not Curative in a Pre-clinical Model of Myelodysplastic Syndrome." PLoS One 2017.
Cita MLAChung, Yang Jo, Terry J. Fry, i Peter D. Aplan. "Myeloablative Hematopoietic Stem Cell Transplantation Improves Survival but Is Not Curative in a Pre-clinical Model of Myelodysplastic Syndrome." PLoS One 2017.
Atenció: Aquestes cites poden no estar 100% correctes.